3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
28
Stomach Neoplasms
7
Esophageal Neoplasms
6
Inflammatory Breast Neoplasms
4
Adenocarcinoma Of Esophagus
3
Triple Negative Breast Neoplasms
2
Neoplasms
2
Sarcoma
1
Her2-Positive Breast Cancer
1
Esophageal Squamous Cell Carcinoma
1
Breast Neoplasms, Male
1
Adenocarcinoma
1
Interventions
Gemcitabine
18
Cisplatin
12
Oxaliplatin
7
pembrolizumab
6
Nivolumab
6
Capecitabine
4
trametinib
3
Fluorouracil
3
Bevacizumab
3
tremelimumab
2
lenvatinib
2
durvalumab
2
derazantinib
2
atezolizumab
2
Trastuzumab
2
Ramucirumab
2
Radiofrequency Ablation
2
Panitumumab
2
Leucovorin
2
Cryosurgery
2
zanidatamab
1
vandetanib
1
tucatinib
1
tocilizumab
1
telotristat ethyl
1
sargramostim
1
rucaparib
1
regorafenib
1
pertuzumab
1
milademetan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Biliary Tract Neoplasms
×
Epirubicin
×
Clear all
No trials found.